Starting the week of Sept. 22, Ontario residents aged 60 to 74 who meet certain high-risk criteria or live in specific higher ...

Toronto — Ontario is rolling out an expanded fall immunization campaign aimed at protecting residents from a seasonal surge ...

GSK faces U.S. vaccine sales declines as Shingrix and Arexvy stumble. Penmenvy approval and pipeline efforts may aid long-term growth.

The American Academy of Family Physicians has released its fall immunization recommendations for COVID-19, RSV, and influenza.

Each year in the U.S., an estimated 58,000 to 80,000 children younger than 5 are hospitalized due to RSV, according to the ...

Two new real-world studies estimate the effectiveness of a single dose of a respiratory syncytial virus (RSV) vaccine against ...

Pfizer achieved 10% year-over-year Q2 2025 revenue growth to $14.7 billion. Click here to find out why PFE stock is a Buy.

Starting this fall, the province will offer protection to all infants who are less than eight months old, and to anyone over ...

Pfizer's strong Q2 results, high dividend yield, and bullish chart fuel optimism despite patent losses and rising competition ...

Pfizer and Bristol Myers Squibb are trading for less than $50 per share. Despite patent cliffs and other issues they face, both could rebound. Both have strong dividend programs and look attractive at ...

Please note: An image of the missing person is available on NSW Police Force social media sites. Police are appealing for assistance to locate a teenage boy missing from the state’s Central Coast.

Pfizer and Bristol Myers Squibb are trading for less than $50 per share. Despite patent cliffs and other issues they face, both could rebound. Both have strong dividend programs and look attractive at ...